D. Caillot

1.9k total citations · 2 hit papers
17 papers, 1.1k citations indexed

About

D. Caillot is a scholar working on Infectious Diseases, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Caillot has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Pharmacology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Caillot's work include Antifungal resistance and susceptibility (4 papers), Pleural and Pulmonary Diseases (3 papers) and Blood disorders and treatments (3 papers). D. Caillot is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Pleural and Pulmonary Diseases (3 papers) and Blood disorders and treatments (3 papers). D. Caillot collaborates with scholars based in France and United States. D. Caillot's co-authors include Olivier Casasnovas, J.F. Couaillier, Éric Solary, Christine M. Durand, Alain Bernard, B. Cuisenier, Alain Bonnin, H. Guy, Monique Dumas and F Piard and has published in prestigious journals such as Journal of Clinical Oncology, The Annals of Thoracic Surgery and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

D. Caillot

17 papers receiving 1.0k citations

Hit Papers

Improved management of invasive pulmonary aspergillosis i... 1997 2026 2006 2016 1997 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Caillot France 8 567 544 394 362 320 17 1.1k
Yosr Hicheri France 18 311 0.5× 342 0.6× 423 1.1× 282 0.8× 183 0.6× 51 1.1k
Shanti Natarajan‐Amé France 14 685 1.2× 637 1.2× 91 0.2× 243 0.7× 127 0.4× 26 1.1k
Hilde Demuynck Belgium 11 284 0.5× 266 0.5× 217 0.6× 153 0.4× 121 0.4× 28 689
Thomas Südhoff Germany 10 345 0.6× 346 0.6× 161 0.4× 230 0.6× 145 0.5× 16 695
C Ferry France 14 199 0.4× 324 0.6× 480 1.2× 289 0.8× 122 0.4× 26 1.0k
Karin Bilger France 21 392 0.7× 520 1.0× 873 2.2× 339 0.9× 134 0.4× 41 1.6k
Alejandro Restrepo United States 11 236 0.4× 255 0.5× 286 0.7× 219 0.6× 209 0.7× 38 711
Jutta Auberger Austria 15 492 0.9× 512 0.9× 57 0.1× 316 0.9× 116 0.4× 26 944
Nancy Bunin United States 9 494 0.9× 480 0.9× 109 0.3× 177 0.5× 42 0.1× 11 795
Manuel Jurado Spain 15 227 0.4× 210 0.4× 253 0.6× 131 0.4× 123 0.4× 37 670

Countries citing papers authored by D. Caillot

Since Specialization
Citations

This map shows the geographic impact of D. Caillot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Caillot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Caillot more than expected).

Fields of papers citing papers by D. Caillot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Caillot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Caillot. The network helps show where D. Caillot may publish in the future.

Co-authorship network of co-authors of D. Caillot

This figure shows the co-authorship network connecting the top 25 collaborators of D. Caillot. A scholar is included among the top collaborators of D. Caillot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Caillot. D. Caillot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
McCarthy, Philip L., Sarah A. Holstein, Maria Teresa Petrucci, et al.. (2017). Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis. Journal of Clinical Oncology. 35(29). 3279–3289. 392 indexed citations breakdown →
2.
Sautour, Marc, Ingrid Lafon, C. Legouge, et al.. (2015). Infection pulmonaire invasive à Trichoderma longibrachiatum : à propos d’un cas. Journal de Mycologie Médicale. 25(3). 240–240. 2 indexed citations
3.
Blay, F. de, et al.. (2010). Amélioration du processus décisionnel pour l’application du décret APSI : l’expérience française. Revue française d'allergologie. 50(3). 141–145. 4 indexed citations
4.
Maillard, Natacha, Pascal Foucher, D. Caillot, et al.. (1999). Transient Pulmonary Infiltrates during Treatment with Anti-Thymocyte Globulin. Respiration. 66(3). 279–282. 12 indexed citations
5.
Caillot, D., Olivier Casasnovas, Alain Bernard, et al.. (1997). Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.. Journal of Clinical Oncology. 15(1). 139–147. 514 indexed citations breakdown →
6.
Bernard, Alain, D. Caillot, J.F. Couaillier, et al.. (1997). Surgical Management of Invasive Pulmonary Aspergillosis in Neutropenic Patients. The Annals of Thoracic Surgery. 64(5). 1441–1447. 71 indexed citations
7.
Hennequin, Christophe, M. Rabodonirina, A. Datry, et al.. (1997). Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO.. PubMed. 35(2). 107–14. 35 indexed citations
8.
Meyer, P, D. Caillot, S. Dalac, et al.. (1996). Sclérodermie systémique et cancers: 21 observations et revue de la littérature. La Revue de Médecine Interne. 17(10). 810–813. 19 indexed citations
9.
Mugneret, Francine, Éric Solary, Bernardine Favre, et al.. (1992). New case of t(3;17)(q26;q22) as an additional change in a Philadelphia-positive chronic myelogenous leukemia in acceleration. Cancer Genetics and Cytogenetics. 60(1). 90–92. 9 indexed citations
10.
Chavanet, P., et al.. (1990). Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistantStaphylococcus aureus infection in rabbits. European Journal of Clinical Microbiology & Infectious Diseases. 9(4). 271–275. 11 indexed citations
11.
Portier, H., et al.. (1990). Les schemas d'Antibiotherapie des infections a staphylocoques a coagulase negative (SCN). Médecine et Maladies Infectieuses. 20. 55–61. 1 indexed citations
12.
Brichon, Pierre-Yves, et al.. (1989). [Extramedullary pancreatic localization of myeloma].. PubMed. 140(5). 421–2. 1 indexed citations
13.
Goudet, Pierre, et al.. (1988). [Retrospective echographic surveillance of a population of patients splenectomized for hematologic reasons. Thrombosis of the portal vein is rare].. PubMed. 114(5). 383–6. 4 indexed citations
14.
Chagué, F., C Sgro, D. Caillot, et al.. (1987). [Agranulocytosis caused by cinepazide maleate. 2 case reports].. PubMed. 42(1). 67–67. 1 indexed citations
15.
Guy, H., et al.. (1987). [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].. PubMed. 16(43). 2172–5. 2 indexed citations
16.
Chavanet, P., et al.. (1987). [Treatment of bacterial infections by ofloxacin. 42 cases].. PubMed. 35(5). 620–3. 1 indexed citations
17.
Bonnin, Alain, et al.. (1985). Périhépatite et maladie lupique. La Revue de Médecine Interne. 6(3). 301–302. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026